Research Article

Differential Regulation of Cardiac Function and Intracardiac Cytokines by Rapamycin in Healthy and Diabetic Rats

Table 2

Summary of 2D M-Mode, pulse wave, and tissue Doppler echo measurements on 20-week-old ZL-C and ZO-C and Rapamycin-treated (ZL-Rap and ZO-Rap) rats. Values are mean ± SE. Numbers in parentheses are sample sizes. ZL-C versus ZO-C; ZO-C versus ZO-Rap; ZL-C versus ZL-Rap; ZL-Rap versus ZO-Rap.

ParameterMain effect valueZL-C (4)ZL-R (4)ZO-C (4)ZO-R (4)

HRStrain0.019360 ± 16389 ± 12349 ± 10
Treatment0.441
Interaction0.114

SWTd, cmStrain0.0010.15 ± 0.000.15 ± 0.000.17 ± 0.01
Treatment0.147
Interaction0.308

PWTd, cmStrain0.0040.16 ± 0.000.17 ± 0.000.19 ± 0.01
Treatment0.116
Interaction0.734

LVIDd, cmStrain0.7570.73 ± 0.020.67 ± 0.020.74 ± 0.010.65 ± 0.03
Treatment0.003
Interaction0.597

RWTStrain0.0010.42 ± 0.010.48 ± 0.020.48 ± 0.02
Treatment0.001
Interaction0.163

LA, cmStrain0.0400.28 ± 0.010.31 ± 0.030.40 ± 0.030.29 ± 0.03
Treatment0.135
Interaction0.017

E′, m·s−1Strain0.0010.078 ± 0.0140.123 ± 0.0090.060 ± 0.007
Treatment0.037
Interaction0.016

E/EStrain0.01316.2 ± 3.39.5 ± 1.219.8 ± 3.7
Treatment0.340
Interaction0.152

E′/AStrain0.0161.20 ± 0.252.48 ± 0.321.09 ± 0.18
Treatment0.025
Interaction0.036

VpStrain0.01165 ± 663 ± 453 ± 7
Treatment0.256
Interaction0.465

E/VpStrain0.0241.78 ± 0.201.83 ± 0.082.26 ± 0.482.70 ± 0.17
Treatment0.374
Interaction471

IVRTStrain0.00119 ± 1.716.7 ± 0.626.0 ± 1.1
Treatment0.919
Interaction0.100

MPIStrain0.0050.41 ± 0.030.38 ± 0.010.48 ± 0.030.48 ± 0.03
Treatment0.487
Interaction0.553

HR, heart rate; SWTd, septal wall thickness-diastole; PWTd, posterior wall thickness-diastole; LVIDd, LV inner dimension-diastole; RWT, relative wall thickness; LA, left atrial diameter; E, velocity of early mitral flow; E′, peak velocity of septal annulus; E/E′ index of LA filling pressure; Vp, flow propogation velocity; E/Vp, index of LV filling pressure; IVRT, isovolumic relaxation time; MPI, myocardial performance index.